Literature DB >> 22797981

Differentiation between Parkinson disease and other forms of Parkinsonism using support vector machine analysis of susceptibility-weighted imaging (SWI): initial results.

S Haller1, S Badoud, D Nguyen, I Barnaure, M-L Montandon, K-O Lovblad, P R Burkhard.   

Abstract

OBJECTIVES: To diagnose Parkinson disease (PD) at the individual level using pattern recognition of brain susceptibility-weighted imaging (SWI).
METHODS: We analysed brain SWI in 36 consecutive patients with Parkinsonism suggestive of PD who had (1) SWI at 3 T, (2) brain (123)I-ioflupane SPECT and (3) extensive neurological testing including follow-up (16 PD, 67.4 ± 6.2 years, 11 female; 20 OTHER, a heterogeneous group of atypical Parkinsonism syndromes 65.2 ± 12.5 years, 6 female). Analysis included group-level comparison of SWI values and individual-level support vector machine (SVM) analysis.
RESULTS: At the group level, simple visual analysis yielded no differences between groups. However, the group-level analyses demonstrated increased SWI in the bilateral thalamus and left substantia nigra in PD patients versus other Parkinsonism. The inverse comparison yielded no supra-threshold clusters. At the individual level, SVM correctly classified PD patients with an accuracy above 86 %.
CONCLUSIONS: SVM pattern recognition of SWI data provides accurate discrimination of PD among patients with various forms of Parkinsonism at an individual level, despite the absence of visually detectable alterations. This pilot study warrants further confirmation in a larger cohort of PD patients and with different MR machines and MR parameters.

Entities:  

Mesh:

Year:  2012        PMID: 22797981     DOI: 10.1007/s00330-012-2579-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  37 in total

Review 1.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

2.  Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects.

Authors:  Domenico Aquino; Alberto Bizzi; Marina Grisoli; Barbara Garavaglia; Maria Grazia Bruzzone; Nardo Nardocci; Mario Savoiardo; Luisa Chiapparini
Journal:  Radiology       Date:  2009-07       Impact factor: 11.105

3.  Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

Authors:  Stephen M Smith; Thomas E Nichols
Journal:  Neuroimage       Date:  2008-04-11       Impact factor: 6.556

Review 4.  Iron: a pathological mediator of Alzheimer disease?

Authors:  Glenda M Bishop; Stephen R Robinson; Quan Liu; George Perry; Craig S Atwood; Mark A Smith
Journal:  Dev Neurosci       Date:  2002       Impact factor: 2.984

5.  Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging.

Authors:  Y Wang; S R Butros; X Shuai; Y Dai; C Chen; M Liu; E M Haacke; J Hu; H Xu
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-03       Impact factor: 3.825

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X-ray fluorescence.

Authors:  Karla Hopp; Bogdan F Gh Popescu; Richard P E McCrea; Sheri L Harder; Christopher A Robinson; Mark E Haacke; Ali H Rajput; Alex Rajput; Helen Nichol
Journal:  J Magn Reson Imaging       Date:  2010-06       Impact factor: 4.813

8.  Individual voxel-based subtype prediction can differentiate progressive supranuclear palsy from idiopathic Parkinson syndrome and healthy controls.

Authors:  Niels K Focke; Gunther Helms; Sebstian Scheewe; Pia M Pantel; Cornelius G Bachmann; Peter Dechent; Jens Ebentheuer; Alexander Mohr; Walter Paulus; Claudia Trenkwalder
Journal:  Hum Brain Mapp       Date:  2011-01-18       Impact factor: 5.038

9.  Determination of brain iron content in patients with Parkinson's disease using magnetic susceptibility imaging.

Authors:  Wei Zhang; Sheng-Gan Sun; Yu-Hong Jiang; Xian Qiao; Xin Sun; Yan Wu
Journal:  Neurosci Bull       Date:  2009-12       Impact factor: 5.203

10.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

View more
  22 in total

1.  Correlation between neuromelanin-sensitive MR imaging and (123)I-FP-CIT SPECT in patients with parkinsonism.

Authors:  Keita Kuya; Yuki Shinohara; Fuminori Miyoshi; Shinya Fujii; Yoshio Tanabe; Toshihide Ogawa
Journal:  Neuroradiology       Date:  2016-01-16       Impact factor: 2.804

2.  Susceptibility-weighted imaging improves the diagnostic accuracy of 3T brain MRI in the work-up of parkinsonism.

Authors:  F J A Meijer; A van Rumund; B A C M Fasen; I Titulaer; M Aerts; R Esselink; B R Bloem; M M Verbeek; B Goraj
Journal:  AJNR Am J Neuroradiol       Date:  2014-10-22       Impact factor: 3.825

3.  Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease.

Authors:  M Cosottini; D Frosini; I Pesaresi; G Donatelli; P Cecchi; M Costagli; L Biagi; R Ceravolo; U Bonuccelli; M Tosetti
Journal:  AJNR Am J Neuroradiol       Date:  2014-11-06       Impact factor: 3.825

Review 4.  Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Authors:  Beatrice Heim; Florian Krismer; Roberto De Marzi; Klaus Seppi
Journal:  J Neural Transm (Vienna)       Date:  2017-04-04       Impact factor: 3.575

5.  Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study.

Authors:  Koji Kamagata; Tomoya Nakatsuka; Ryuji Sakakibara; Yohei Tsuyusaki; Tomohiro Takamura; Kanako Sato; Michimasa Suzuki; Masaaki Hori; Kanako K Kumamaru; Tsutomu Inaoka; Shigeki Aoki; Hitoshi Terada
Journal:  Neuroradiology       Date:  2016-12-29       Impact factor: 2.804

6.  Chemical exchange saturation transfer MR imaging of Parkinson's disease at 3 Tesla.

Authors:  Chunmei Li; Shuai Peng; Rui Wang; Haibo Chen; Wen Su; Xuna Zhao; Jinyuan Zhou; Min Chen
Journal:  Eur Radiol       Date:  2014-07-20       Impact factor: 5.315

7.  A full-brain, bootstrapped analysis of diffusion tensor imaging robustly differentiates Parkinson disease from healthy controls.

Authors:  F M Skidmore; P G Spetsieris; T Anthony; G R Cutter; K M von Deneen; Y Liu; K D White; K M Heilman; J Myers; D G Standaert; A C Lahti; D Eidelberg; A M Ulug
Journal:  Neuroinformatics       Date:  2015-01

8.  Parkinson's disease: diagnostic potential of high-resolution phase difference enhanced MR imaging at 3 T.

Authors:  Shingo Kakeda; Yukunori Korogi; Tetsuya Yoneda; Keita Watanabe; Junji Moriya; Yu Murakami; Toru Sato; Yasuhiro Hiai; Norihiro Ohnari; Satoru Ide; Kazumasa Okada; Takenori Uozumi; Sadatoshi Tsuji; Toshinori Hirai; Yasuyuki Yamashita
Journal:  Eur Radiol       Date:  2012-10-19       Impact factor: 5.315

9.  Iron Accumulation Is Not Homogenous among Patients with Parkinson's Disease.

Authors:  Khashayar Dashtipour; Manju Liu; Camellia Kani; Pejman Dalaie; Andre Obenaus; Daniel Simmons; Nicole M Gatto; Mehran Zarifi
Journal:  Parkinsons Dis       Date:  2015-04-05

10.  Changes of brain gray matter structure in Parkinson's disease patients with dementia.

Authors:  Jianguo Xia; Jinlin Miu; Hongbin Ding; Xiuping Wang; Hua Chen; Juan Wang; Juan Wu; Jingli Zhao; Huanxin Huang; Weizhong Tian
Journal:  Neural Regen Res       Date:  2013-05-15       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.